Richeye Capital

Richeye Capital targets early-stage venture investments, specifically seed rounds and startup financings. The firm operates a generalist venture mandate rather than focusing on a single sector vertical. This early entry point positions the firm to capture value from Hefei's university and industrial research commercialization pipeline.

Richeye Capital's Hefei headquarters suggests deal flow anchored in Anhui province's innovation ecosystem. Hefei is home to the University of Science and Technology of China and multiple national research laboratories focused on quantum physics, materials science, and advanced manufacturing. The firm's geographic positioning points toward sourcing driven by local industrial policy relationships and proximity to state-backed technology transfer programs.

Richeye Capital is structured as a private equity firm deploying venture capital, distinct from a family office or corporate venture arm. The firm has not publicly disclosed its fund architecture, limited partner base, or whether it operates committed capital funds alongside deal-by-deal vehicles. No regulatory filings provide detail on ownership or investment committee composition.

There is no public record of Richeye Capital making investments outside of China. The firm's single-office presence in Hefei and its focus on domestic early-stage ventures suggest an exclusively China-centric mandate. No cross-border deals, international co-investments, or offshore fund structures have been reported.

Richeye Capital's founding principals have not been publicly named in accessible financial media, regulatory databases, or firm communications. The firm operates without a public-facing website or LinkedIn presence as of the latest available record. This opacity is not uncommon among second-tier-city private equity firms in China that raise capital entirely from domestic institutional or government-linked sources.